CytoMed Therapeutics GDTC
NASDAQ GDTC
$0.84 +0.00 (+0.49%)
At close: Nov 11, 2026 · 4:00 PM EST

CytoMed Therapeutics (GDTC) Minority Interest (2021 - 2026)

Updated

CytoMed Therapeutics' Minority Interest was $426,592 in Q2 2026, up 463.7% from $75,681 a year earlier.

Analysis

CytoMed Therapeutics (GDTC) Minority Interest (2021 - 2026) Analysis & Trends

At the end of FY2025, Minority Interest at CytoMed Therapeutics came in at $309,221, up 297.7% from FY2024.

  • In earlier years, Minority Interest was $77,749 in FY2024, -$956.00 in FY2023, -$682.00 in FY2022 and -$439.00 in FY2021.
  • The Q2 2026 figure marks the highest quarterly Minority Interest in data going back to Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 CytoMed Therapeutics 9.94 Mn -2.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 329,644.00
Dec 31, 2025 240,845.08
Jun 30, 2025 59,502.00
Dec 31, 2024 57,199.09
Jun 30, 2024 -812.00
Dec 31, 2023 -724.35
Jun 30, 2023 -608.00
Dec 31, 2022 -507.62
Dec 31, 2021 -324.73
API Access

CytoMed Therapeutics Minority Interest API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=minority-interest&ticker=GDTC&period=max&api_key=YOUR_API_KEY